Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 3 (2007), Issue 10 (October)

1. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
   Nat Rev Drug Discov, 6(10): 811-20. [Abstract] [Full-text]
2. Flying under the radar: the new wave of BCR-ABL inhibitors.
   Nat Rev Drug Discov, 6(10): 834-48. [Abstract] [Full-text]
3. A systematic review of randomised clinical trials of individualised herbal medicine in any indication.
   Postgrad Med J, 83(984): 633-7. [Abstract] [Full-text]
4. Review on modelling aspects in reversed-phase liquid chromatographic quantitative structure-retention relationships.
   Anal Chim Acta, 602(2): 164-72. [Abstract] [Full-text]
5. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
   Bioorg Med Chem, 15(23): 7399-407. [Abstract] [Full-text]
6. The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.
   Bioorg Med Chem, 15(23): 7434-43. [Abstract] [Full-text]
7. Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent.
   Bioorg Med Chem, 15(23): 7361-7. [Abstract] [Full-text]
8. Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure.
   Bioorg Med Chem, 15(23): 7237-47. [Abstract] [Full-text]
9. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
   Bioorg Med Chem, 15(23): 7258-73. [Abstract] [Full-text]
10. Advances in solid dosage form manufacturing technology.
    Philos Transact A Math Phys Eng Sci, 365(1861): 2935-49. [Abstract] [Full-text]
11. Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury.
    Nat Rev Cancer, 7(11): 870-9. [Abstract] [Full-text]
12. Anthrax vaccine and public health policy.
    Am J Public Health, 97(11): 1945-51. [Abstract] [Full-text]
13. Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design.
    Biochem J, 408(1): 131-8. [Abstract] [Full-text]
14. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Biomed Microdevices, 9(6): 845-53. [Abstract] [Full-text]
15. The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis.
    Toxicology, 241(3): 157-66. [Abstract] [Full-text]
16. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.
    Nat Rev Drug Discov, 6(11): 904-16. [Abstract] [Full-text]
17. The influence of drug-like concepts on decision-making in medicinal chemistry.
    Nat Rev Drug Discov, 6(11): 881-90. [Abstract] [Full-text]
18. Target deconvolution strategies in drug discovery.
    Nat Rev Drug Discov, 6(11): 891-903. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.